The relationship between bifidobacteria and allergic asthma and/or allergic dermatitis: A prospective study of 0-3 years-old children in Turkey

Anaerobe

Volumn 28, Issue , 2014, Pages 98-103

  Akay, Hatice Kubra ^a   Bahar Tokman, Hrisi ^a   Hatipoglu, Nevin ^b   Hatipoglu, Huseyin ^b   Siraneci, Rengin ^b   Demirci, Mehmet ^a   Borsa, Baris Ata ^c   Yuksel, Pelin ^a   Karakullukcu, Asiye ^a   Kangaba, Achille Aime ^a   Sirekbasan, Serhat ^a   Aka, Sibel ^d   Mamal Torun, Muzeyyen ^a,e   Kocazeybek, Bekir S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Kanuni Sultan Suleyman Education and Research Hospital   (Turkey)

^c ALTINBAS UNIVERSITY   (Turkey)

^d ACIBADEM UNIVERSITY   (Turkey)

^e BAHCESEHIR UNIVERSITY   (Turkey)

Author keywords

Allergic asthma; Allergic dermatitis; Bifidobacteria; Children; Turkey

Indexed keywords

ALLERGIC ASTHMA; ARTICLE; BACTERIAL COUNT; BACTERIUM DETECTION; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; BIFIDOBACTERIUM PSEUDOCATENULATUM; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FECES LEVEL; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN ALLERGY; SPECIES DISTRIBUTION; TURKEY (REPUBLIC); ASTHMA; BIFIDOBACTERIALES INFECTION; BIFIDOBACTERIUM; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DERMATITIS, ATOPIC; FECES; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; TURKEY;

ASTHMA; BIFIDOBACTERIALES INFECTIONS; BIFIDOBACTERIUM; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; FECES; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; TURKEY;

EID: 84904637352     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.05.006     Document Type: Article

References (43)

1. Neish A. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.
2. Gerritsen J., Smidt H., Rijkers G.T., de Vos W.M. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011, 6:209-240.
3. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003, 22:360-366.
4. Sommer F., Backhed F. The gut microbiota - masters of host development and physiology. Nat Rev Microbiol 2013, 11:227-238.
5. Bengmark S. Ecological control of the gastrointestinal tract: the role of probiotic flora. Gut 1998, 42:2-7.
6. Saavedra J.M. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr Clin Pract 2007, 22:351-365.
7. Garssen J., Herreilers M., Loveren H., Vos J., Opperhuizen A. Immunomodulation by probiotics: a literature survey 2003, 6-33. RIVM Report 340320001, Bilthoven.
8. Soccol1 C.R., Vandenberghe L.P.S., Spier M.R., Medeiros A.B.P., Yamaguishi C.T., Lindner J.D.D., et al. The potential of probiotics: a review. Food Technol Biotechnol 2010, 48(4):413-434.
9. Rowland I.R., Rumney C.J., Coutts J.T., ve Lievense L.C. Effect of Bifidobacterium longum and inulin a gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carsinogenesis 1998, 19:281-285.
10. Klaver F.A.M., Van Der Meer R. The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugation activity. Appl Environ Microbiol 1993, 59:1120-1124.
11. Leung D.Y., Tharp M., Boguniewicz M. Atopic dermatitis. Fitzpatrick's dermatology in general medicine 1999, 1464-1480. Mc Graw Hill Press, Newyork. 5th ed. T.B. Fitzpatrick, A.Z. Eisen, K. Wolf, I.M. Freedberg, K.F. Austen (Eds.).
12. Sears M.R., Grene J.M., Willan A.R., Taylor D.R., Flannery E.M., Covan J.O., et al. Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet 2002, 360:901-907.
13. Rada V., Petr J. Enumeration of bifidobacteria in animal intestinal sample. Vet Med 2002, 47:1-4.
14. Ferraris L., Aires J., Waligora-Dupriet A.J., Butel M.J. New selective medium for selection of bifidobacteria from human feces. Anaerobe 2010, 16:469-471.
15. Sozzi T., Brigidi P., Mignot O., Matteuzzi D. Use of dicloxacillin for the isolation and counting of Bifid bacteria from dairy products. Lait 1990, 70:357-361.
16. Bonaparte C. Selective isolation and taxonomic position of bifidobacteria isolated from commercial fermented dairy products in Central Europe 1997, Berlin Technical University Dissertation, Schüling, Münster, DE.
17. Citron D.M. Rapid identification of anaerobes in the clinical laboratory. Anaerobe 1999, 5:109-113.
18. Jousimies-Somer H., Summanen P., Citron D.M., Baron E.J., Wexler H.M., Finegold S.M. Wadsworth-KTL anaerobic bacteriology manual 2002, Star Publishing, Belmont, CA. 6th ed.
19. Matsuki T., Watanabe K., Tanaka R. Genus- and species-specific PCR primers for the detection and identification of bifidobacteria. Curr Issues Intest Microbiol 2003, 4:61-69.
20. Junick J., Blaut M. Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl Environ Microbiol 2012, 78:2613-2622.
21. Murray C.S., Woodcock A. Gut microflora and atopic disease. Probiotics and prebiotics: where are we going? 2002, 239-261. Caister Academic Press, Wymondham, UK. G.W. Tannock (Ed.).
22. Šmehilová M., Vlková E., Nevoral J., Flajšmanová K., Killer J., Rada V. Comparison of intestinal microflora in healthy infants and infants with allergic colitis. Folia Microbiol 2008, 53:255-258.
23. Tanaka J., Watanabe N., Kido M., Saga K., Akamatsu T., Nishio A., et al. Human TSLP and TLR3 ligands promote differentiation of the Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 2009, 39:89-100.
24. Walligora-Dupriet A.J., Campetto F., Romero K., Mangin I., Rouzard G., Ménard O., et al. Diversity of gut bifidobacterium species is not altered between allergic and non- allergic French infants. Anaerobe 2011, 17:91-96.
25. Michail S. Review: the role of probiotics in allergic diseases. Allergy Asthma Clin Immunol 2009, 5:5.
26. Young S.L., Simon M.A., Baird M.A., Tannock G.W., Bibiloni R., Spencely K., et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 2004, 11:686-690.
27. Grönlund M.M., Gueimonde M., Laitinen K., Kociubinski G., Grönroos T., Salminen S. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007, 37:1764-1772.
28. Kleessen B., Bunke H., Tovar K., Noack J., Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr Intern J Paediatr 1995, 84:1347-1356.
29. Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 1999, 65:4506-4512.
30. Gueimonde M., Laitinen K., Salminen S., Isolauri E. Breast milk: a source of bifidobacteria for infant gut development and maturation. Neonatol 2007, 92:64-66.
31. He F., Ouwehand A.C., Isolauri E., Hosoda M., Benno Y., Salminen S. Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr Microbiol 2001, 43:351-354.
32. Kool M., Hammad H., Lambrecht B.N. Cellular networks controlling Th2 polarization in allergy and immunity. F1000 Biol Rep 2012, 4:6.
33. Kormann M.S., Depner M., Hartl D., Klopp N., Illig T., Adamski J., et al. Toll-like receptor heterodimer variants protect from childhood asthma. JAllergy Clin Immunol 2008, 122:86-92.
34. Tantisira K., Klimecki W.T., Lazarus R., Palmer L.J., Raby B.A., Kwiatkowski D.J., et al. Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma. Genes Immun 2004, 5:343-346.
35. Hayashi T., Raz E. TLR9-based immunotherapy for allergic disease. Am J Med 2006, 119:897.
36. Feleszko W., Jaworska J., Hamelmann E. Toll-like receptors-novel targets in allergic airway disease (probiotics, friends and relatives). Eur J Pharmacol 2006, 533:308-318.
37. Deniz G., van de Veen W., Akdis M. Natural killer cells in patients with allergic diseases. JAllergy Clin Immunol 2013, 132:527-535.
38. Taylor A., Verhagen J., Blaser K., Akdis M., Akdis A.C. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 2006, 117:433-442.
39. Ventura M., Turroni F., Lugli G.A., van Sinderen D. Bifid bacteria and humans: our special friends, from ecological to genomics perspectives. JSci Food Agric 2014, 94:163-168.
40. Takahashi N., Kitazawa H., Iwabuchi N., Xiao J.Z., Miyaji K., Iwatsuki K., et al. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin Exp Immunol 2006, 145:130-138.
41. McLoughlin R.M., Mills K.H.G. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. JAllergy Clin Immunol 2011, 127:1097-1107.
42. Noverr M.C., Huffnagle G.B. Does the microbiota regulate immune responses outside the gut. Trends Microbiol 2004, 12:562-568.
43. Vael C., Nelen V., Verhulst S.L., Goossens H., Desager K.N. Early intestinal Bacteroides fragilis colonisation and development of asthma. BMC Pulm Med 2008, 8:19.